Epidemiological and cytological aspects of the cervix in women from the Diourbel region (Senegal) cervical smear screening

Amadou Ndiade; Ibou Thiam; Abdou Karim Diallo; Ange Lucien Diatta; Fabrice Senghor; Oumar Faye

doi:10.18203/2320-1770.ijrcog20204780

Authors

Amadou Ndiade Laboratory of Clinical Cytology, Cytogenetics, Reproductive Biology and Human Development, Heinrich Lubcke Regional Hospital of Diourbel, Senegal http://orcid.org/0000-0001-7127-0196
Ibou Thiam Laboratory of Anatomy Cytology Pathology, Faculty of Medicine, Pharmacy and Dentistry, Cheikh Anta Diop University, Dakar, Senegal
Abdou Karim Diallo Gynecological and Obstetric Clinic, Le Dantec Hospital, Dakar, Senegal
Ange Lucien Diatta Department of Biology and Functional Exploration, FRU of Health Sciences, Assane Seck University of Ziguinchor
Fabrice Senghor Department of Biology and Functional Exploration, FRU of Health Sciences, Assane Seck University of Ziguinchor
Oumar Faye Histology-Embryology Laboratory, Department of Biology and Functional Explorations, Faculty of Medicine, Pharmacy and Odontology, Cheikh Anta Diop University, Dakar, Senegal

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20204780

Keywords:

Cervical smear, Dysplasia, Cervical cancer

Abstract

Background: Objectives of the study were to record the results of uterine cervical smear tests of women in the Diourbel region to compare epidemiological data with the results of uterine cervical smear tests.

Methods: This was a retrospective study of 201 satisfactory cervical smears performed in the period from 01 December 2018 to 01 December 2019 at the laboratory of the regional hospital Henrich Lubcke of Diourbel. All women with a satisfactory smear were included in our study, so we classified patients according to age and parity.

Results: The mean age of the patients was 38.41 years with a standard deviation of 11.51 years. The extremes were 15 and 64 years. The age group (30-40 years) was in the majority at 32.34%. Multiparous patients were in the majority, accounting for 43.28%. The cervix was macroscopically healthy in 61.19% of patients and inflammatory in 12.94%. There was 18.41% low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL) accounted for 1% of smears. A statistically significant relationship existed between parity and smear result with p˂0.01.

Conclusions: Cervical cancer is one of the most fatal cancers in women and the smear remains the safest and most effective means of prevention.

Metrics

Metrics Loading ...

Author Biography

Amadou Ndiade, Laboratory of Clinical Cytology, Cytogenetics, Reproductive Biology and Human Development, Heinrich Lubcke Regional Hospital of Diourbel, Senegal

formation and resaech unity in health and sustainable developement

References

World Health Organization (WHO). Cervical Cancer Control; A Guide to Essential Practices. Second Edition.2014.2017. Available at: https://apps.who.int/iris/bitstream/handle/10665/254713/9789242548952-fre.pdf.

Anaes (Agence nationale d’accréditation et d’évaluation en santé). Evaluation de l'intérêt de la recherche des papillomavirus humains (HPV) dans le dépistage des lésions précancéreuses et cancéreuses du col de l'utérus. 2004. J Gynecol Obstet Biol Reprod 2005;34:166-9.

Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374-403.

Gabrielli S, Maggioni E, Fieschi L. Cervical cancer prevention in Senegal: an International Cooperation. Project Report Acta Biomed for Health Professions. 2018;89(6):29-34.

Plummer M, DE Martel C, Vignat J, Ferlay J, Bray F, Francheschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4:609-16.

Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus‐positive head and neck squamous cell carcinoma. J Clin Oncol. 2015;33:3235-442.

Bryan JT, Buckland B, Hammond J, Jansen KU. Prevention of cervical cancer: journey to develop the first human papillomavirus virus‐like particle vaccine and the next generation vaccine. Curr Opin Chem Biol. 2016;32:34-47.

Cutts FT, Francheschi S, Goldie S, Castellsague X, de Sanjose S, Garnett G, et al. Human papillomavirus and HPV vaccines: a review. Bull World Health Organ. 2007;85:719-26.

International Agency for Research on Cancer (IARC)/World Health Organization (WHO). Globocan 2012: Cervical Cancer Estimated Incidence, Mortality and Prevalence Worldwide in 2012. Lyon, France; IARC. 2012. Available at: http://globocan.iarc.fr/old/FactSheets/cancers/cervix‐new.asp. Accessed on: 25 July 2020.

Dayyani F, Etzel CJ, Liu M, Ho CH, Lippman SM, Tsao AS. Meta‐analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol. 2010;2:15.

SY DM, Faye O, Mbaye EHS, Diallo AS, Gueye MV, Diop N, Dem A. Dépistage primaire de cancer du col de l’utérus par frottis cervico vaginal et typage HPV dans le district de Mbao au Sénégal. Journal de Biologie Clinique. 2016;9-13.

Ndiade A. Bilan du dépistage cytologique en 2016 par frottis cervico vaginal au laboratoire d’histologie embryologie et cytogénétique du chu Le Dantec. Ucad mémoire Numéro. 2016;283:41-4.

Afoutou JM et al. Une décénie de dépistage colpocytologique Journal des sciences. 2008;8:21-6.

Wikipedia, the free encyclopedia. Cervix. 2014. Available at: https://fr.wikipedia.org/wiki/Col_de_l%27ut%C3%A9rus. Accessed on: 25 July 2020.

Tebeu PM, Sandjong I, Nkele N, Fokoua A, Achu P, Kuam L, et al. Lésion précancéreuses du col utérin étude transversale. Médecine d’Afrique Noire. 2005;51(1):28-31.

N’guessou K, Kouakou F, Loué V, Angoi V, Abauleth Y, Boni S. Le cancer du col de l’utérus aspects épidémiologique et prise en charge en milieu africain, mali médical 2009 tome XXIV. Le Mali Médical. 2009;3:1-2.

Piana L, Leandri FX, Retraite L, Heid P, Tamalet C, Garnier HS. L’auto prélèvement vaginal à domicile pour recherche de papilloma virus à haut risque: campagne expérimentale au département de bouches du Rhones. Bull Cancer. 2011;98:723-31.

Gnaoui NEL, Saile R, Benomamar H. Pap smear an inevitable test in the screening of the lesion of the cervix. J Afr Can. 2010;2(9-13):12.

Diallo AS, Fenton CE, Afoutou JM, Giao MS. Condylomes, dysplasies et carcinomes du col utérin : notre expérience en vingt ans (1980-1999). Dakar Médical. 2003;48(3):181-4.

Okonofua F. Prévention et contrôle du cancer du col en Afrique: Appel à l'action. Af J Reprod Health. 2015;19(1):11-3.